Corrigendum: Progress and perspectives of perioperative immunotherapy in non-small cell lung cancer

Corrigendum: Progress and perspectives of perioperative immunotherapy in non-small cell lung cancer

Библиографические подробности
Главные авторы:	Yurong Peng, Zhuo Li, Yucheng Fu, Yue Pan, Yue Zeng, Junqi Liu, Chaoyue Xiao, Yingzhe Zhang, Yahui Su, Guoqing Li, Fang Wu
Формат:	Статья
Язык:	English
Опубликовано:	Frontiers Media S.A. 2023-03-01
Серии:	Frontiers in Oncology
Предметы:	perioperative period perioperative immunotherapy neoadjuvant therapies immunotherapy neoadjuvant immune monotherapy adjuvant therapy biomarkers
Online-ссылка:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1163376/full

Схожие документы

Progress and perspectives of perioperative immunotherapy in non-small cell lung cancer
по: Yurong Peng, и др.
Опубликовано: (2023-01-01)

Neoadjuvant Immunotherapy for Hepatocellular Carcinoma
по: Marron TU, и др.
Опубликовано: (2022-06-01)

Editorial: Optimal perioperative management of urothelial carcinoma
по: Ariane Holzman, и др.
Опубликовано: (2023-05-01)

Perioperative systemic therapies for non-small-cell lung cancer: Recent advances and future perspectives
по: Savvas Lampridis, и др.
Опубликовано: (2023-01-01)

Current status and prospect of perioperative treatment of stage Ⅲ melanoma
по: XU Yu, CHEN Yong, YANG Jilong, ZHU Guannan
Опубликовано: (2022-12-01)

The Impact of Esophageal Oncological Surgery on Perioperative Immune Function; Implications for Adjuvant Immune Checkpoint Inhibition
по: Noel E. Donlon, и др.
Опубликовано: (2022-01-01)

A narrative review on perioperative systemic therapy in non-small cell lung cancer
по: Robert Hsu, и др.
Опубликовано: (2024-07-01)

Application of immune checkpoint inhibitors for resectable gastric/gastroesophageal cancer
по: Feizhi Lin, и др.
Опубликовано: (2024-05-01)

Prognostic Impact of Adjuvant Immunotherapy in Patients With Resectable NSCLC After Neoadjuvant Chemoimmunotherapy: A Brief Report
по: Yichen Dong, MD, и др.
Опубликовано: (2025-01-01)

Systematic review of the perioperative immunotherapy in patients with non-small cell lung cancer: evidence mapping and synthesis
по: Yunfeng Ni, и др.
Опубликовано: (2023-04-01)

Neoadjuvant immunotherapy with ipilimumab/nivolumab induces a complete response of a primary malignant melanoma in an 89 years old patient
по: Pascal Spahn, и др.
Опубликовано: (2024-12-01)

Expert consensus on perioperative comprehensive treatment for high risk prostate cancer (2023 edition)
по: Society of Male Reproductive System Oncology, China Anti-Cancer Association
Опубликовано: (2023-12-01)

Progress and Discussion of Perioperative Targeted Therapy in Patients  with EGFR-mutated Resectable Non-small Cell Lung Cancer
по: Peng SONG, и др.
Опубликовано: (2024-05-01)

Combining surgery and immunotherapy: turning an immunosuppressive effect into a therapeutic opportunity
по: Orneala Bakos, и др.
Опубликовано: (2018-09-01)

The significance of time interval between perioperative SOX/XELOX chemotherapy and clinical decision model in gastric cancer
по: Jun-Bing Chen, и др.
Опубликовано: (2022-12-01)

Advancing neoadjuvant therapies in resectable non-small cell lung cancer: implications for novel treatment strategies and biomarker discovery
по: Hyein Jeon, и др.
Опубликовано: (2024-06-01)

Novel Cellular and Immunotherapy: Toxicities and Perioperative Implications
по: Alessandro De Camilli, и др.
Опубликовано: (2023-08-01)

Perioperative tislelizumab with four cycles of neoadjuvant chemotherapy for resectable locally advanced esophageal squamous cell carcinoma: a phase 2 study
по: Na Zhou, и др.
Опубликовано: (2024-12-01)

The emerging landscape of neo/adjuvant immunotherapy in renal cell carcinoma
по: Pooya Dibajnia, и др.
Опубликовано: (2023-01-01)

Immune mechanisms and predictive biomarkers related to neoadjuvant immunotherapy response in stage III melanoma
по: Amanda Braga Figueiredo, и др.
Опубликовано: (2024-06-01)

Impact of neoadjuvant targeted therapy on perioperative complications in patients with localized reno-cellular cancer
по: O. A. Voylenko, и др.
Опубликовано: (2020-05-01)

The impact of neoadjuvant and adjuvant immunotherapy on the survival of pancreatic cancer patients: a retrospective analysis
по: Saber Amin, и др.
Опубликовано: (2020-06-01)

Ang2 inhibitors and Tie2 activators: potential therapeutics in perioperative treatment of early stage cancer
по: Kabir A Khan, и др.
Опубликовано: (2021-06-01)

Progress of Neoadjuvant Immunotherapy for Non-small Cell Lung Cancer
по: Chao GUO, и др.
Опубликовано: (2022-07-01)

Application and challenge of immunotherapy in perioperative therapy of gastric cancer
по: XUE Chi, GAO Peng, ZHU Zhi, WANG Zhenning
Опубликовано: (2024-03-01)

The hype around ctDNA guiding an informed perioperative therapeutic strategy in early-stage non-small cell lung cancer
по: Gaia Passarella, и др.
Опубликовано: (2025-01-01)

Perioperative Treatment in EGFR‐Mutant Early‐Stage Non‐Small Cell Lung Cancer: Current Evidence and Future Perspectives
по: Xiaobei Guo, и др.
Опубликовано: (2025-02-01)

Update on the Management of Stage III NSCLC: Navigating a Complex and Heterogeneous Stage of Disease
по: Arani Sathiyapalan, и др.
Опубликовано: (2023-10-01)

Progress in Neoadjuvant Immunotherapies for Resectable Non-small Cell Lung Cancer
по: Shuaibo WANG, и др.
Опубликовано: (2020-05-01)

Perioperative chemotherapy versus adjuvant chemotherapy treatment for resectable locally advanced gastric cancer: a retrospective cohort study
по: Pengfei Su, и др.
Опубликовано: (2023-10-01)

Comparative efficacy and safety of first-line neoadjuvant therapy for early-stage non-small cell lung cancer based on immune checkpoint inhibitor therapy: a systematic review and network meta-analysis
по: Linfeng Wang, и др.
Опубликовано: (2025-01-01)

A Meta‐Analysis of Efficacy and Safety of Neoadjuvant Immunotherapy Plus Chemotherapy for Resectable Non‐Small Cell Lung Cancer
по: Xinru Sun, и др.
Опубликовано: (2024-10-01)

Evaluation of neoadjuvant immunotherapy and traditional neoadjuvant therapy for resectable esophageal cancer: a systematic review and single-arm and network meta-analysis
по: Hesong Wang, и др.
Опубликовано: (2023-05-01)

Small molecule inhibitors as adjuvants in cancer immunotherapy: enhancing efficacy and overcoming resistance
по: Xiaolin Wu, и др.
Опубликовано: (2024-08-01)

Evaluation of neoadjuvant immunotherapy plus chemotherapy in Chinese surgically resectable gastric cancer: a pilot study by meta-analysis
по: Hao Xu, и др.
Опубликовано: (2023-06-01)

Immunotherapy during the Immediate Perioperative Period: A Promising Approach against Metastatic Disease
по: Elad Sandbank, и др.
Опубликовано: (2023-08-01)

Role of Perioperative Immune Checkpoint Inhibitors in Muscle Invasive Bladder Cancer
по: Saachi Chhaya, и др.
Опубликовано: (2023-01-01)

Preliminary Efficacy Evaluation of Neoadjuvant Immunotherapy Combined with  Chemotherapy in Resectable Non-small Cell Lung Cancer
по: Shijie ZHOU, и др.
Опубликовано: (2021-06-01)

Perioperative Treatment of Gastric Cancer in New Era of Immunity
по: YANG Tianning, и др.
Опубликовано: (2023-06-01)

Does perioperative systemic therapy represent the optimal therapeutic paradigm in organ-confined, muscle-invasive urothelial carcinoma?
по: Luca Scafuri, и др.
Опубликовано: (2021-10-01)